19 Presidential Way - Woburn, MAWoburn, MA Metabolix, Inc., an advanced biomaterials company focused on sustainable solutions for the plastics industry, has signed a 10-year lease agreement for 30,000 s/f of laboratory and office space at 19 Presidential Way. Metabolix, who will exit its current space in Cambridge, expects to take occupancy of its new corporate headquarters in June. JLL represented Metabolix in the lease.
Don Domoretsky, JLLJLL executive vice president Don Domoretsky said, “Metabolix’s relocation to the growing north suburban bio-hub of Woburn is a win-win scenario. Metabolix remains firmly supplanted within the world’s leading life science cluster while benefiting from a reduction in operating spend and an upgrade in operations.”
“Access to the vibrant biotechnology community of Greater Boston was an important factor in evaluating re-location options,” said Joseph Shaulson, president and CEO of Metabolix. “With the new space in Woburn, we will be able to upgrade and expand our biopolymer applications development lab to support customer projects as we continue to ramp up our PHA biopolymer market development activities and work to transition from pilot scale to commercial scale operations. The move also allows us to reduce our overall footprint as we consolidate our Massachusetts operations into 19 Presidential Way and significantly reduce facilities-related leasing and operating costs starting in 2017.”
As part of the relocation, Metabolix also plans to exit office space it currently occupies in Lowell, Massachusetts in May 2017 and to consolidate its biopolymers sales, marketing and administrative offices and biopolymers research and development laboratories in the new Woburn facility. The new laboratory facilities will include a microbial fermentation lab and an expanded biopolymers applications development lab. Pending the spinout of its Yield10 crop science program, Metabolix will also relocate its Massachusetts based crop science laboratory and personnel to the new facility in Woburn.
Metabolix, Inc. is an innovation-driven specialty materials company focused on delivering high- performance biopolymer solutions to customers in the plastics industry. Metabolix’s Mirel® biopolymers, which are derived from renewable resources, are a family ofbiobased performance additives and specialty resins based on PHA (polyhydroxyalkanoates). Metabolix’s proprietary biotechnology platform enables the creation of specialty biopolymers for use in a broad range of applications such as construction andpackaging materials, as well as industrial, consumer and personal care products.
JLL (NYSE: JLL) is a professional services and investment management firm offering specialized real estate services to clients seeking increased value by owning, occupying and investing in real estate. With annual fee revenue of $4.7 billion and gross revenue of $5.4 billion, JLL has more than 230 corporate offices, operates in 80 countries and has a global workforce of approximately 58,000. On behalf of its clients, the firm provides management and real estate outsourcing services for a property portfolio of 3.4 billion square feet, or 316 million square meters, and completed $118 billion in sales, acquisitions and finance transactions in 2014. Its investment management business, LaSalle Investment Management, has $57.2 billion of real estate assets under management. JLL is the brand name, and a registered trademark, of Jones Lang LaSalle Incorporated. For further information, visit www.jll.com.
